miércoles, 8 de marzo de 2017

España: Estamos en Instagram...: Bayer, Boehringer, Menarini...


Instagram may become the social medium of choice for pharma marketers now that it has been purchased by Facebook and has added several new features that allow marketers to potentially thwart FDA regulations.

These new features include :
• Stories
• Disappearing Video
• Ephemeral Messages

This article reviews these new features and how they may be used by pharma marketers. Included is a review of Big Pharma Instagram accounts.


Publicar un comentario